Moreover, the immunohistochemical analyses of tumor samples revealed that 11a-1 treatment reduced Ki67 level and elevated cleaved PARP level (Figure 6F), indicating that 11a-1 attenuated tumor cell proliferation and enhanced tumor cell apoptosis in vivo. This evidence concerns the gene MKI67 and neoplasm.